Enzon Pharmaceuticals, Inc.

BST:EZ1 Stock Report

Market Cap: €5.6m

Enzon Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Enzon Pharmaceuticals has a total shareholder equity of $46.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $47.0M and $410.0K respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$46.23m
EquityUS$46.58m
Total liabilitiesUS$410.00k
Total assetsUS$46.99m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: EZ1's short term assets ($46.6M) exceed its short term liabilities ($410.0K).

Long Term Liabilities: EZ1 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: EZ1 is debt free.

Reducing Debt: EZ1 has not had any debt for past 5 years.

Debt Coverage: EZ1 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: EZ1 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies